WCM Investment Management Portfolio holdings
AUM
$43.8B
This Quarter Return
+5.99%
1 Year Return
+46.92%
3 Year Return
+145.55%
5 Year Return
+234.7%
10 Year Return
+793.48%
AUM
$43.3B
AUM Growth
+$43.3B
(+9.9%)
Cap. Flow
+$2.91B
Cap. Flow
% of AUM
6.74%
Top 10 Holdings %
Top 10 Hldgs %
54.6%
Holding
214
New
18
Increased
155
Reduced
27
Closed
10
Top Buys
| 1 |
Atlassian
TEAM
|
$1.5B |
| 2 |
Icon
ICLR
|
$802M |
| 3 |
Repligen
RGEN
|
$361M |
| 4 |
Floor & Decor
FND
|
$355M |
| 5 |
Lam Research
LRCX
|
$297M |
Top Sells
| 1 |
HDFC Bank
HDB
|
$897M |
| 2 |
Synopsys
SNPS
|
$294M |
| 3 |
Mercado Libre
MELI
|
$132M |
| 4 |
West Pharmaceutical
WST
|
$101M |
| 5 |
NBIS
Nebius Group N.V. Class A Ordinary Shares
NBIS
|
$65.5M |
Sector Composition
| 1 | Technology | 37.18% |
| 2 | Healthcare | 25.21% |
| 3 | Consumer Discretionary | 15.3% |
| 4 | Industrials | 8.74% |
| 5 | Financials | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
CryoPort
CYRX
$426M
| $9.5M | 0.02% |
142,777
+961
| +0.7% | +$63.9K |
|
127
APi Group
APG
$14.4B
| $9.36M | 0.02% |
459,849
+17,606
| +4% | +$358K |
|
128
Q2 Holdings
QTWO
$4.83B
| $9.27M | 0.02% |
115,636
+806
| +0.7% | +$64.6K |
|
|
LHCG
129
DELISTED
LHC Group LLC
LHCG
| $9.1M | 0.02% |
57,988
+578
| +1% | +$90.7K |
|
130
Clarus
CLAR
$134M
| $9M | 0.02% |
+351,053
| New | +$9M |
|
131
Shift4
FOUR
$6.06B
| $8.84M | 0.02% |
+114,043
| New | +$8.84M |
|
|
BHVN
132
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $8.48M | 0.02% |
61,034
-21,179
| -26% | -$2.94M |
|
133
Elastic
ESTC
$9.17B
| $8.26M | 0.02% |
55,432
+12,793
| +30% | +$1.91M |
|
|
CCF
134
DELISTED
Chase Corporation
CCF
| $8.21M | 0.02% |
80,400
+2,152
| +3% | +$220K |
|
135
Toast
TOST
$24.7B
| $8.15M | 0.02% |
+163,126
| New | +$8.15M |
|
136
Mercury Systems
MRCY
$4.04B
| $7.9M | 0.02% |
166,639
+954
| +0.6% | +$45.2K |
|
137
AtriCure
ATRC
$1.73B
| $7.89M | 0.02% |
113,414
-44,938
| -28% | -$3.13M |
|
138
Pacific Biosciences
PACB
$378M
| $7.72M | 0.02% |
302,234
-644
| -0.2% | -$16.5K |
|
|
ONEM
139
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $7.55M | 0.02% |
372,634
+2,731
| +0.7% | +$55.3K |
|
140
Arrowhead Research
ARWR
$3.84B
| $7.45M | 0.02% |
119,341
+31,909
| +36% | +$1.99M |
|
141
Natera
NTRA
$23B
| $7.28M | 0.02% |
65,281
-39,456
| -38% | -$4.4M |
|
142
Ultragenyx Pharmaceutical
RARE
$3.04B
| $6.62M | 0.02% |
73,412
+506
| +0.7% | +$45.6K |
|
143
Surgery Partners
SGRY
$2.89B
| $6.57M | 0.02% |
155,088
+1,014
| +0.7% | +$42.9K |
|
144
Insmed
INSM
$30.3B
| $6.22M | 0.01% |
225,815
+66,316
| +42% | +$1.83M |
|
145
AdaptHealth
AHCO
$1.23B
| $5.92M | 0.01% |
254,230
-225,389
| -47% | -$5.25M |
|
|
NSTG
146
DELISTED
NanoString Technologies, Inc.
NSTG
| $5.87M | 0.01% |
122,160
+763
| +0.6% | +$36.6K |
|
147
Fate Therapeutics
FATE
$115M
| $5.55M | 0.01% |
93,621
+501
| +0.5% | +$29.7K |
|
148
Halozyme
HALO
$8.75B
| $5.52M | 0.01% |
135,726
+578
| +0.4% | +$23.5K |
|
149
Ligand Pharmaceuticals
LGND
$3.25B
| $4.19M | 0.01% |
30,068
+147
| +0.5% | +$20.5K |
|
150
Snap
SNAP
$12.3B
| $4.16M | 0.01% |
56,273
+12,818
| +29% | +$947K |
|